Rating Change
Barclays reiterated its Overweight rating on Waters Corporation (NYSE:WAT) on October 07, 2026.
Barclays reiterated its Overweight rating on Waters Corporation (NYSE:WAT) on October 07, 2026.

At publication ·
Waters Corporation (NYSE:WAT) · reiterate
At a glance
Barclays reiterated its Overweight rating on Waters Corporation (NYSE:WAT) on October 07, 2026.
Waters Corporation operates in the Healthcare sector. The stock currently trades at $435.84 with a market capitalization of $23.4B. The stock has gained 13.6% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Waters Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 07, 2026 | Barclays | Overweight | N/A |
| Oct 01, 2026 | Guggenheim | Buy | N/A |
| Sep 21, 2026 | Goldman Sachs | Buy | N/A |
| Sep 09, 2026 | UBS | Buy | N/A |
| Aug 27, 2026 | Piper Sandler | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View WAT Stock Page
A rating of Overweight from Barclays reflects the analyst's outlook on Waters Corporation (NYSE:WAT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the WAT forecast page.
Current market data
NYSE · WAT
$433.77
Up: +$4.64 · +1.08%
Live quote updated
Keep reading